P1276: HUMAN UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELL FOR THE TREATMENT OF STEROID-REFRACTORY AGVHD: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND PHASE 2 TRIAL

Bibliographic Details
Main Authors: Dai-Hong Liu, Chen Yao, Donglin Yang, Liping Dou, Xiaoqiang Hou, Kun Qian
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000971992.86050.85
_version_ 1797280210250366976
author Dai-Hong Liu
Chen Yao
Donglin Yang
Liping Dou
Xiaoqiang Hou
Kun Qian
author_facet Dai-Hong Liu
Chen Yao
Donglin Yang
Liping Dou
Xiaoqiang Hou
Kun Qian
author_sort Dai-Hong Liu
collection DOAJ
first_indexed 2024-03-07T16:36:49Z
format Article
id doaj.art-dc914c4663044fa3b6680360402413bf
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T16:36:49Z
publishDate 2023-08-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-dc914c4663044fa3b6680360402413bf2024-03-03T09:43:12ZengWileyHemaSphere2572-92412023-08-017e860508510.1097/01.HS9.0000971992.86050.85202308003-01172P1276: HUMAN UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELL FOR THE TREATMENT OF STEROID-REFRACTORY AGVHD: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND PHASE 2 TRIALDai-Hong Liu0Chen Yao1Donglin Yang2Liping Dou3Xiaoqiang Hou4Kun Qian51 The Fifth Medical Center of Chinese PLA General Hospital, China2 Peking University Clinical Research Institute, Peking University First Hospital3 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College1 The Fifth Medical Center of Chinese PLA General Hospital, China4 Platinumlife Biotechnology (Beijing) Co., Ltd.5 Nankai University, School of Medicine, Tianjin, Chinahttp://journals.lww.com/10.1097/01.HS9.0000971992.86050.85
spellingShingle Dai-Hong Liu
Chen Yao
Donglin Yang
Liping Dou
Xiaoqiang Hou
Kun Qian
P1276: HUMAN UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELL FOR THE TREATMENT OF STEROID-REFRACTORY AGVHD: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND PHASE 2 TRIAL
HemaSphere
title P1276: HUMAN UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELL FOR THE TREATMENT OF STEROID-REFRACTORY AGVHD: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND PHASE 2 TRIAL
title_full P1276: HUMAN UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELL FOR THE TREATMENT OF STEROID-REFRACTORY AGVHD: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND PHASE 2 TRIAL
title_fullStr P1276: HUMAN UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELL FOR THE TREATMENT OF STEROID-REFRACTORY AGVHD: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND PHASE 2 TRIAL
title_full_unstemmed P1276: HUMAN UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELL FOR THE TREATMENT OF STEROID-REFRACTORY AGVHD: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND PHASE 2 TRIAL
title_short P1276: HUMAN UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELL FOR THE TREATMENT OF STEROID-REFRACTORY AGVHD: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND PHASE 2 TRIAL
title_sort p1276 human umbilical cord derived mesenchymal stromal cell for the treatment of steroid refractory agvhd a multicenter randomized double blind phase 2 trial
url http://journals.lww.com/10.1097/01.HS9.0000971992.86050.85
work_keys_str_mv AT daihongliu p1276humanumbilicalcordderivedmesenchymalstromalcellforthetreatmentofsteroidrefractoryagvhdamulticenterrandomizeddoubleblindphase2trial
AT chenyao p1276humanumbilicalcordderivedmesenchymalstromalcellforthetreatmentofsteroidrefractoryagvhdamulticenterrandomizeddoubleblindphase2trial
AT donglinyang p1276humanumbilicalcordderivedmesenchymalstromalcellforthetreatmentofsteroidrefractoryagvhdamulticenterrandomizeddoubleblindphase2trial
AT lipingdou p1276humanumbilicalcordderivedmesenchymalstromalcellforthetreatmentofsteroidrefractoryagvhdamulticenterrandomizeddoubleblindphase2trial
AT xiaoqianghou p1276humanumbilicalcordderivedmesenchymalstromalcellforthetreatmentofsteroidrefractoryagvhdamulticenterrandomizeddoubleblindphase2trial
AT kunqian p1276humanumbilicalcordderivedmesenchymalstromalcellforthetreatmentofsteroidrefractoryagvhdamulticenterrandomizeddoubleblindphase2trial